T1	HMM 905 943	The mean number of chemotherapy cycles
T2	HMM 1119 1145	developed tumor recurrence
T3	HMM 1147 1171	The Median Survival time
T4	HMM 1228 1264	The proportion of patients surviving
T5	HMM 1440 1462	any clinical advantage
